Cogent Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $25.7M | $85.9M | $55.7M |
| FY2019 | $17.7M | $49.4M | $37.4M |
| FY2020 | $16.2M | $250.9M | $242.2M |
| FY2021 | $17.9M | $232.1M | $219.7M |
| FY2022 | $45.1M | $300.8M | $139.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $25.7M | $85.9M | $55.7M |
| FY2019 | $17.7M | $49.4M | $37.4M |
| FY2020 | $16.2M | $250.9M | $242.2M |
| FY2021 | $17.9M | $232.1M | $219.7M |
| FY2022 | $45.1M | $300.8M | $139.9M |